"The probe committee report has come and it has revealed a scam of around Rs 15 crore. It is being analysed further. Those found guilty will not be spared. We'll take stern action against them," Manjhi told reporters on the sidelines of oath taking ceremony for the 10 newly elected MLAs in the recent by-polls.
Manjhi, however, evaded questions on former Chief Minister Nitish Kumar who was also holding the health portfolio during the period corresponding with the scam.
The health department had put the report of medicine scam probe committee, headed by Additional Director (Health) Dr K K Singh, in public domain yesterday.
The report indicted Bihar Medical Services Infrastructure Corporation Limited (BMSICL) Managing Director Praveen Kishore and eight other senior officials for the scam and revealed that drugs worth Rs 14.4 crore out of total Rs 60 crore purchased during January and July this year were bought at inflated prices in comparison to the rate fixed by the State Health Society Bihar (SHSB).
The report also said that drugs worth around Rs 20 crore had been bought from firms which were blacklisted in other states.
Apart from BMSICL MD, the government has decided to show cause eight members of the technical evaluation committee of the health department, which had screened the firms and recommended the prices suggested by them, the minister said.
These include Joint Secretary (Health) Sanjay Kumar (since posted to New Delhi), Director-in-chief (Health) Dr Surendra Kumar, Deputy Director (Industries) Om Prakash Pathak, State Drug Controller Hemant Kumar Sinha, Patna Medical College and Hospital (PMCH) Deputy Superintendent Bimal Karak, SHSB Assistant Director Dr D K Raman, UNFPA representative Haider and BMSICL General Manager (Finance) Tripurari Kumar.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
